✦ LIBER ✦

PCN1 EPOETIN ALFA AND DARBEPOETIN ALFA ANEMIA TREATMENT OUTCOMES IN CANCER PATIENTS FROM A VA PERSPECTIVE

✍ Scribed by FJ Papatheofanis; JM Fastenau; T Chiang; CT Piech

Book ID: 119593060
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62143-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of darbepoetin alfa and epoetin alfa

Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia

✍ Ariel Berger; John Edelsberg; Joel Kallich; Gerry Oster 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 159 KB

PCN37 DIFFERENCES IN TREATMENT PRACTICE,

PCN37 DIFFERENCES IN TREATMENT PRACTICE, RESPONSE RATES AND COST OF EPOETIN ALFA AND DARBEPOETIN ALFA TREATMENT FOR ANEMIC CANCER PATIENTS: A RETROSPECTIVE ANALYSIS FROM SWEDEN

✍ U Persson; S Borg; S Jansson; T Ekman; L Franksson; S Friesland; AM Larsson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Epoetin alfa and darbepoetin alfa for th

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response

✍ Ulf Persson; Sixten Borg; Sandra Jansson; Tor Ekman; Lars Franksson; Signe Fries 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 471 KB

Incidence of symptomatic deep venous thr

Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer

✍ Shannon N. Westin; Elizabeth N. Skinner; Michele Jonsson Funk; Paola M. Gehrig; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Budget Impact Analysis Of Darbepoetin Al

Budget Impact Analysis Of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week For Cancer Patients Receiving Chemotherapy From A Us Payer's Perspective

✍ McGarvey, N.; Shreay, S.; Xu, H.; Corey-Lisle, P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PCN2: DARBEPOETIN ALFA 200 MCG EVERY 2 W

PCN2: DARBEPOETIN ALFA 200 MCG EVERY 2 WEEKS (Q2W) AND EPOETIN ALFA 40,000 UNITS EVERY WEEK (QW) IN CHEMOTHERAPY-INDUCED ANEMIA PATIENTS RESULT IN SIMILAR INITIAL HEMOGLOBIN OUTCOMES

✍ J Patton; JF Wallace 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB